Author: Denisa Bojkova; Jake E. McGreig; Katie-May McLaughlin; Stuart G. Masterson; Marek Widera; Verena Krähling; Sandra Ciesek; Mark N. Wass; Martin Michaelis; Jindrich Cinatl
Title: SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles Document date: 2020_4_5
ID: gpr86lxe_27
Snippet: positions that differ between SARS-CoV-2 and SARS-CoV and nearly 13% of all 387 residues encoded by the SARS-CoV genome. 258 of these DCPs (2.6% of all 388 residues) are likely to have a structural and functional impact. The DCPs are not 389 equally distributed between the proteins. DCPs are enriched in S, 3a, p6, nsp2, 390.....
Document: positions that differ between SARS-CoV-2 and SARS-CoV and nearly 13% of all 387 residues encoded by the SARS-CoV genome. 258 of these DCPs (2.6% of all 388 residues) are likely to have a structural and functional impact. The DCPs are not 389 equally distributed between the proteins. DCPs are enriched in S, 3a, p6, nsp2, 390
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date